International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064




Downloads: 2 | Views: 149 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Dermatology | Qatar | Volume 12 Issue 10, October 2023 | Rating: 5.4 / 10 | Rate this Article


Biological Treatment of Psoriasis: A Different Life

Leyla Abed Rassul | Sabah Ramadan Hussein Ahmed [3]


Abstract: Psoriasis has a significant detrimental effect on quality of life and is linked to both anxiety and depression. The introduction of biologics has improved treatment outcomes, but it is not well understood how patients feel about these gains. Aims of the current study was to address the advantages and disadvantages of biologics as a first - line treatment option and revise treatment guidelines in light of new research. The comorbid conditions are included in our discussion. Additionally; to discuss the effect of COVID - 19 on psoriasis patients. Furthermore; to investigate the daily activities of psoriasis patients getting biological therapy in order to better understand their requirements and the care they receive. Methodology: The current study was searched using a variety of key words such as "biologic therapy" "psoriasis", "psoriatic arthritis", "Type of psoriasis", "psoriasis and/or complications", "psoriasis and/or COVID", "psoriasis and/or interstitial pneumonia", "inteleukin - 23" and "interluekin - 17". Those articles were derived from the data related to Psoriasis and reported cases were conducted utilizing seven electronic databases (CINAHL, MEDLINE, ProQuest, PubMed, Scopus, Science Direct, and Cochrane) for studies published in various languages from January 2023 to September 2023. According to the findings, psoriasis is a prevalent inflammatory skin illness with major medical and psychosocial comorbidities that is primarily genetically determined. The number of therapy options available to people with psoriasis is growing as a result of improvements in our understanding of the disease's aetiology. biological treatments that reduce systemic inflammation may improve cardiovascular outcomes in psoriasis patients. Similar to how metabolic syndromecan be well controlled by medicine or lifestyle modifications, psoriasis signs and symptoms may improve as a result.


Keywords: biologic therapy, psoriasis, biologics, psoriasis, psoriatic arthritis, tumour necrosis factor, inteleukin-23, interluekin-17, Psoriasis, biologics, COVID-19, psoriasis


Edition: Volume 12 Issue 10, October 2023,


Pages: 1173 - 1190


How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link


Verification Code will appear in 2 Seconds ... Wait

Top